Explore the competitive landscape of Mucopolysaccharidosis I (Hurler syndrome) Therapeutics. In 2024, over 1,740 cases were diagnosed across 16 countries. With one FDA-approved drug, the pipeline ...

Explore the competitive landscape of Mucopolysaccharidosis I (Hurler syndrome) Therapeutics. In 2024, over 1,740 cases were diagnosed across 16 countries. With one FDA-approved drug, the pipeline ...

Measurements of the curvature of the cornea of the eye can be significantly affected by the status of dry eye in a patient, according to a study published in Frontiers in Medicine. 1 Different ...

The promising Mucopolysaccharidosis type I therapies in the pipeline include OTL-203, Lepunafusp alfa (JR-171), RGX-111, Iduronicrin genleukocel-T (ISP-001), and others.

If we look carefully at any patient’s cornea, natural lens or intact posterior capsule, there are always some opacities. Most are not visually significant and do not require surgical intervention.

There is a need to perform about 1,00,000 corneal transplants every year, but only 30% of this need is being met. On the demand side, many fellow citizens lead a lifetime of avoidable sight loss ...

One and a half years after the cortisone therapy was begun, the right cornea (Fig. 1 B) had only a trace of opacity (not visible to the unaided eye), and the only opacity grossly evident in the ...

India is reeling under a critical need for corneal transplants, with over 100,000 transplants required annually whereas only 25,000 out of these requirements are met each year. This makes it ...

Following treatment, all participants achieved a corneal endothelial cell density of more than 500 cells per square millimeter, with ten eyes having a density exceeding 1000 cells per square ...

Corneal transplant surgery has come a long way since its inception in 1905. This surgical procedure involves the replacement of a damaged or diseased cornea with a healthy one.

Medications and their Potential to Cause Increase 'Corneal opacity' Developed by - Dr. M. Janani Priya, Pharm D Reviewed by - Dr. M. Sree Mohana Preetha, Pharm D Last Updated on Nov 16, 2023 ...

Opacity persisted to 9 months after the limbal stem cell transplant, but had improved by 12 months. The patient's best corrected visual acuity (BCVA) improved from 20/40 to 20/30.